Jane McBride-Carter

Jane Mcbride-Carter is an experienced healthcare professional with a robust background in pharmaceutical marketing and physical therapy. Currently serving as the US HCP Lead for Prevnar 13 and Prevnar 20 at Pfizer since May 2001, Jane has also held various significant positions including Global C. Difficile HCP and Consumer Lead, Tanezumab Launch Lead, and Director of US Marketing for Quillivant. Jane's earlier roles in the industry include Senior Manager on the Eliquis Marketing Team and Hospital Sales Specialist. Prior to joining Pfizer, Jane practiced as a physical therapist specializing in Orthopedics and Pediatrics. Educational qualifications include a BA in Biology from Dartmouth College, an MA in Applied Physiology from Teachers College, Columbia University, and a degree in Physical Therapy from Stony Brook University.